BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32242993)

  • 1. Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk.
    Vuorio A; Watts GF; Kovanen PT
    J Intern Med; 2020 Jun; 287(6):746-747. PubMed ID: 32242993
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and the Heart.
    Strabelli TMV; Uip DE
    Arq Bras Cardiol; 2020 Apr; 114(4):598-600. PubMed ID: 32236325
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.
    Banach M; Penson PE; Fras Z; Vrablik M; Pella D; Reiner Ž; Nabavi SM; Sahebkar A; Kayikcioglu M; Daccord M;
    Pharmacol Res; 2020 Aug; 158():104891. PubMed ID: 32389859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?
    De Piero ME; Lo Coco V; Taccone FS; Belliato M; Broman LM; Malfertheiner MV; Lorusso R
    Innovations (Phila); 2020; 15(4):317-321. PubMed ID: 32634058
    [No Abstract]   [Full Text] [Related]  

  • 5. ECG: essential in care of patients with COVID-19.
    Lam K; McClelland S; Dallo MJ
    Med J Aust; 2020 Nov; 213(10):476-476.e1. PubMed ID: 33098111
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of SARS-CoV-2 on the cardiovascular system: More issues to be addressed.
    Liu Y
    Anatol J Cardiol; 2020 Aug; 24(2):121-123. PubMed ID: 32749243
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Krittanawong C; Virk HUH; Narasimhan B; Wang Z; Narasimhan H; Zhang HJ; Sun T; Messerli FH
    Prog Cardiovasc Dis; 2020; 63(4):527-528. PubMed ID: 32389584
    [No Abstract]   [Full Text] [Related]  

  • 8. Return to play after the COVID-19 pandemic: a commentary by the Editor in Chief.
    Pelliccia A
    J Sports Med Phys Fitness; 2020 May; 60(5):675-676. PubMed ID: 32438782
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
    Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Call to action for the cardiovascular side of COVID-19.
    Emanueli C; Badimon L; Martelli F; Potočnjak I; Carpusca I; Robinson EL; Devaux Y
    Eur Heart J; 2020 May; 41(19):1796-1797. PubMed ID: 32282026
    [No Abstract]   [Full Text] [Related]  

  • 11. Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID-19 Pandemic.
    Ward RP; Lee L; Ward TJ; Lang RM
    J Am Soc Echocardiogr; 2020 Jun; 33(6):690-691. PubMed ID: 32503708
    [No Abstract]   [Full Text] [Related]  

  • 12. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.
    Linschoten M; Asselbergs FW
    Eur Heart J; 2020 May; 41(19):1795-1796. PubMed ID: 32267494
    [No Abstract]   [Full Text] [Related]  

  • 13. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.
    Yang C; Jin Z
    JAMA Cardiol; 2020 Jul; 5(7):743-744. PubMed ID: 32211809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):189-194. PubMed ID: 32234175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priority plan for invasive cardiac electrophysiology procedures during the coronavirus disease 2019 (COVID-19) pandemic.
    Wang NC; Jain SK; Estes NAM; Barrington WW; Bazaz R; Bhonsale A; Kancharla K; Shalaby AA; Voigt AH; Saba S
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1255-1258. PubMed ID: 32323382
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidance for Health Care Providers on Management of Cardiovascular Complications in Patients Suspected or Confirmed with COVID 19 Virus Infection.
    Alexander T; Thomson VS; Malviya A; Mohan B; Wander GS; S H; Seth S; Reddy S; Arulrhaj S; Shah S; Joshi S; Tiwaskar M; Nadkar M; Tewary K
    J Assoc Physicians India; 2020 May; 68(5):46-49. PubMed ID: 32610866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scientific statement on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):565-566. PubMed ID: 32842268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection.
    Siddiqi HK; Neilan TG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):347-348. PubMed ID: 32367343
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticipating the long-term cardiovascular effects of COVID-19.
    Becker RC
    J Thromb Thrombolysis; 2020 Oct; 50(3):512-524. PubMed ID: 32880795
    [No Abstract]   [Full Text] [Related]  

  • 20. [A gastrointestinal overview of COVID-19].
    Konturek PC
    MMW Fortschr Med; 2020 Apr; 162(8):59-60. PubMed ID: 32342369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.